Vertex Pharmaceuticals Is Acquiring Semma Therapeutics

Vertex Pharmaceutical (VRTX) entered into a definitive agreement to buy a private company, Semma Therapeutics. Semma uses stem cell-derived human islets as a potential cure for type 1 diabetes.

Semma’s major scientific advances include: an ability to produce large quantities of functional human pancreatic beta cells that could . . .